To The Moon

$Hims & Hers Health Inc.(HIMS)$ $DEFIANCE DAILY TARGET 2X LONG HIMS ETF(HIMZ)$ 🔥💊🚀 Prescribe Volatility: $HIMS Isn’t Just a Squeeze, It’s a Paradigm Shift 🚀💊🔥 When political policy converges with a parabolic chart and borrow rates set fire to short books, you get $HIMS, a health-tech juggernaut now fuelled by structural momentum and algorithmic inevitability. This isn’t noise, it’s narrative alignment. And it’s turning bears into brand ambassadors. 📈 From $25 to $58.60 in Two Weeks: Biotech Breakthrough or Rocket Trajectory? $HIMS has doubled YTD and exploded 135% in just 14 sessions, piercing through prior resistance with conviction. Friday’s intraday high hit $58.60, confirming a high-volume surge to levels not seen since early 2024. With price now eyeing $72.98, the left-side peak, and volume expanding in tandem, this is more than momentum. It’s a technical manifesto. The breakout has now formed a vertical angle of ascent riding the 5-DSMA, classic of institutions loading at speed. This isn’t luck. It’s the byproduct of policy, platform, and pressure. 🧠 Trump’s Executive Order: From Politics to Profits On 12May25, President Trump signed a sweeping EO aimed at aligning U.S. drug prices with those of global benchmarks. The EO encourages direct-to-consumer platforms. $HIMS was built for this exact model. “If the executive order catalyzes broader adoption of direct-to-consumer pricing, that would be a positive for HIMS given its infrastructure.” ~ Leerink Partners Execution still matters. Many EOs go unenforced. But the market is pre-pricing the optionality. This isn’t theoretical. It’s asymmetric leverage for a platform with no middlemen and full-stack scalability. 🕯️ Short Sellers Are Paying the Price, Literally The setup is becoming punitive: • Short interest: 24.83 million shares • Short ratio: 12.02% • Borrow fee: 0.97, tripled in 10 days • Daily short volume: 7.44 million • ATR: 11.2% This isn’t just a short squeeze. It’s a liquidity trap. Borrow fees this high indicate scarcity, and that scarcity forces risk managers to de-risk fast. As price rises, pain compounds. We are now in the early stages of a reflexive unwind. The irony? HIMS sells hair loss solutions. Its short sellers are about to become paying customers. 📊 Wall Street Missed the Memo 15 analysts remain tethered to stale models: • Average target: $44.10 • Lowest: $25.00 • Highest: $85.00 With price already hitting $58.60, 80% of these targets are irrelevant. This is where opportunity lives, in the dislocation between narrative and consensus. The HIMZ ETF, up 14.68% intraday, is a retail acceleration play now gaining traction fast. 📐 The Bigger Picture: Fibonacci and the $869 Horizon This breakout aligns with a textbook Elliott Wave structure: • Wave 1 target: $73.06 (2.618) • Wave 3 projection: $263.96 (2.618) • 2035 horizon: $869 per share, implying a $200B market cap These projections match the platform’s expansion trajectory. A more conservative $100B target by 2030 aligns with approximately $420 per share, in sync with internal revenue forecasts and market TAM. This isn’t moon math. It’s disciplined Fibonacci extensions supported by platform economics. 🌐 Macro Tailwinds: The Perfect External Catalyst Stack • U.S. tariffs cut from 145% to 30% • China slashes theirs from 125% to 10% • Bipartisan momentum for DTC healthcare • HIMZ 2x ETF showing leveraged inflows • Retail dominance merging with institutional scale This is the kind of macro setup that doesn’t just support a trade. It defines a cycle. 🎯 What to Watch This Week 1. Price break above $58.60, then $72.98 2. Borrow fee surpassing 1.0 3. EO enforcement by regulators 4. HIMZ ETF volume confirming retail re-entry 🧨 The Contrarian Insight: This Isn’t Telehealth Labeling $HIMS a “telehealth play” misses the mark. It’s a vertically integrated healthcare platform combining prescription automation, dermatology, wellness, and behavioural health. With customer LTV rivaling insurance models, $HIMS is replacing, not disrupting, legacy infrastructure. This isn’t a trade. It’s a thesis. 📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀 Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀 @Tiger_comments @TigerPicks @TigerStars @TigerWire @Daily_Discussion